Cancer Cause and Prevention Research in Nebraska
Cancer Cause and Prevention Research (93.393) awarded $8.4 million to recipients in Nebraska in 9 grants from fiscal 2021 to 2025, 0.2% of the program's national total. Board of Regents of the University of Nebraska received the most, $7.1 million.
- Awarded in Nebraska$8.4 million
- Awards9
- Share of the program0.2%
- Rank among states37th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $1.2 million |
| FY 2022 | 5 | $1.3 million |
| FY 2023 | 6 | $1.4 million |
| FY 2024 | 7 | $2.0 million |
| FY 2025 | 4 | $2.4 million |
Recipients in Nebraska
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Board of Regents of the University of Nebraska | Colleges and universities | 8 | $7.1 million |
| Creighton University | Colleges and universities | 1 | $1.3 million |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Nebraska?
$8.4 million from fiscal 2021 to 2025, across 9 awards. Nebraska ranks 37th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Nebraska?
The largest recipient is Board of Regents of the University of Nebraska, with $7.1 million in 8 awards. Next is Creighton University.
Can organizations in Nebraska apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Nebraska
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Children's Health Insurance Program
- Special Education Grants to States
- Broadband Equity, Access, and Deployment Program
- Greenhouse Gas Reduction Fund: Clean Communities Investment Accelerator